{
    "clinical_study": {
        "@rank": "72148", 
        "arm_group": [
            {
                "arm_group_label": "0.9% saline", 
                "arm_group_type": "Experimental", 
                "description": "In each group, patients received either 0.9% normal saline or plasmalyte solution until end of surgery."
            }, 
            {
                "arm_group_label": "plasmalyte", 
                "arm_group_type": "Active Comparator", 
                "description": "In each group, patients received either 0.9% normal saline or plasmalyte solution until end of surgery."
            }
        ], 
        "brief_summary": {
            "textblock": "Chloride-rich isotonic crystalloid solutions have been shown to exert electrolyte imbalance\n      and metabolic acidosis in critically ill patients. The aim of this investigation is to\n      compare the influence of 0.9% saline and plasmalyte solution on acid-base balance and\n      electrolytes in healthy patients undergoing major spine surgeries."
        }, 
        "brief_title": "The Aim of This Investigation is to Compare the Influence of 0.9% Saline and Plasmalyte Solution on Acid-base Balance and Electrolytes in Healthy Patients Undergoing Major Spine Surgeries.", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "condition": "Spinal Surgery", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        1.50 patients (aged 20-65) undergoing cervical or lumbar spine surgery who were diagnosed\n        spinal stenosis involving more than tow spinal levels.\n\n        Exclusion Criteria:\n\n          1. ASA class III or IV\n\n          2. pregnancy\n\n          3. breast feeding\n\n          4. lack of mental weakness(including disabled)\n\n          5. using diuretics\n\n          6. respiratory insufficiency\n\n          7. metabolic acidosis or alkalosis\n\n          8. coagulation disorder\n\n          9. over hydtration\n\n         10. renal failure or serum creatinine > 1.4mg/dl\n\n         11. anemia (Hemoglobin 9.0<mg/dl)\n\n         12. hypernatremia (Na > 145mEq/L)\n\n         13. Hyperkalemia (K>5.5mEq/L)\n\n         14. psychological medication or any drugs that influences renal clearance"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01855542", 
            "org_study_id": "4-2012-0059"
        }, 
        "intervention": [
            {
                "arm_group_label": "0.9% saline", 
                "description": "In each group, patients received either 0.9% normal saline or plasmalyte solution until end of surgery.", 
                "intervention_name": "0.9% normal saline", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "plasmalyte", 
                "description": "In each group, patients received either 0.9% normal saline or plasmalyte solution until end of surgery.", 
                "intervention_name": "plasmalyte", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "metabolic acidosis, plasmalyte solution, 0.9% normal saline", 
        "lastchanged_date": "May 13, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "base-excess", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline in base-excess at postoperative 12 h"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01855542"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}